<DOC>
	<DOCNO>NCT02398955</DOCNO>
	<brief_summary>Biomime stent novel sirolimus-eluting stent ( SES ) ( Meril Life Sciences Pvt . Ltd. , Gujarat , India ) ultra-thin stent platform ( 65 Î¼m ) biodegradable polymer license treatment de novo coronary lesion . However data regard efficacy safety stent `` all-comers '' patient population treat percutaneus coronary intervention ( PCI ) publish far . In registry investigator aim collect clinical angiographic information extensive `` all-comers '' employ novel stent .</brief_summary>
	<brief_title>Biomime Stent All-comers PCI Patients Registry</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>coronary artery disease treat percutaneous coronary intervention Biomime stent patient &lt; 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Drug-Eluting Stents</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Absorbable Implants</keyword>
</DOC>